Objective:We examined the utility of distinguishing between patients with frontotemporal lobar degeneration (FTLD) and Alzheimer disease (AD) using quantitative cerebral blood flow (CBF) imaging with arterial spin labeled (ASL) perfusion MRI.
Methods:Forty-two patients with FTLD and 18 patients with AD, defined by autopsy or CSFderived biomarkers for AD, and 23 matched controls were imaged with a continuous ASL method to quantify CBF maps covering the entire brain.
Results:Patients with FTLD and AD showed distinct patterns of hypoperfusion and hyperperfusion. Compared with controls, patients with FTLD showed significant hypoperfusion in regions of the frontal lobe bilaterally, and hyperperfusion in posterior cingulate and medial parietal/precuneus regions. Compared with controls, patients with AD showed significant hypoperfusion in the medial parietal/precuneus and lateral parietal cortex, and hyperperfusion in regions of the frontal lobe. Direct comparison of patient groups showed significant inferior, medial, and dorsolateral frontal hypoperfusion in FTLD, and significant hypoperfusion in bilateral lateral temporal-parietal and medial parietal/precuneus regions in AD.Conclusions: Doubly dissociated areas of hypoperfusion in FTLD and AD are consistent with areas of significant histopathologic burden in these groups. ASL is a potentially useful biomarker for distinguishing patients with these neurodegenerative diseases. Neurology ® 2010;75:881-888 GLOSSARY A42 ϭ -amyloid 1-42 ; AD ϭ Alzheimer disease; ASL ϭ arterial spin labeling; bvFTD ϭ behavioral-variant frontotemporal dementia; cASL ϭ continuous arterial spin labeling; CBS ϭ corticobasal syndrome; CBF ϭ cerebral blood flow; dACC ϭ dorsal anterior cingulate cortex; dlPFC ϭ dorsolateral prefrontal cortex; FDR ϭ false detection rate; FTLD ϭ frontotemporal lobar degeneration; GM ϭ gray matter; iFC ϭ inferior frontal cortex; MCI ϭ mild cognitive impairment; MNI ϭ Montreal Neurological Institute; mTC ϭ middle temporal cortex; OFC ϭ orbital frontal cortex; PC ϭ parietal cortex; PCA ϭ principal component analysis; PCC ϭ posterior cingulate cortex; PPA ϭ primary progressive aphasia; PRC ϭ precuneus; PVE ϭ partial volume effect; t-tau ϭ total tau; TE ϭ echo time; TI ϭ inversion time; TR ϭ repetition time; WM ϭ white matter.Frontotemporal lobar degeneration (FTLD) is the most common cause of progressive cognitive decline in young-onset dementia. Because Alzheimer disease (AD) accounts for 30% of cases presenting with a clinical diagnosis of primary progressive aphasia (PPA) or behavioral-variant frontotemporal dementia (bvFTD), 1,2 it is important to distinguish between FTLD and AD so that appropriate treatments can be initiated. This distinction is difficult on clinical grounds alone, because AD can mimic PPA and bvFTD, 1,2 and FTLD can present with a memory disorder.